ClinicalTrials.Veeva

Menu
N

Nova Scotia Health | Hepatology Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Metreleptin
Levothyroxine
BAY2927088
Ziltivekimab
Lemborexant
Ticagrelor
Rivaroxaban

Parent organization

This site is a part of Nova Scotia Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 25 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations. Before a treatment can be approved for...

Begins enrollment in 1 month
Advanced Solid Tumors
HER2 Mutation
Drug: BAY2927088

This is a feasibility study investigating the use of a high-performance HyperSight cone beam CT (CBCT) and adaptive planning software for both online...

Active, not recruiting
Head and Neck Cancer
Device: CBCT Imaging

This is a Phase III, double-blind, placebo-controlled, safety and efficacy study of daily SC metreleptin in subjects with Partial Lipodystrophy.

Enrolling
Partial Lipodystrophy
Drug: metreleptin
Drug: Placebo

Trial sponsors

N
AbbVie logo
V
A
Bayer logo
McMaster University logo
Novo Nordisk logo
University Health Network, Toronto logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems